Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 230.00
Bid: 228.00
Ask: 232.00
Change: 7.00 (3.13%)
Spread: 4.00 (1.754%)
Open: 222.00
High: 232.00
Low: 231.00
Prev. Close: 224.00
DATA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Nov 2020 07:00

RNS Number : 3967G
GlobalData PLC
25 November 2020
 

25 November 2020

GlobalData Plc

Trading Update

Continued strong performance, full year outlook in-line with expectations

GlobalData PLC, the global provider of data, analytics, and insights, provides the following trading update for the 10 months to 31 October 2020 (the "period").

 

Key highlights:

 

· Revenue excluding events grew by +5% compared to the 10 months ended 31 October 2019 (the "previous period"), driven by 7% growth in subscription revenue. Overall Group revenue is flat versus the previous period.

 

· Forward contracted revenue increase of +8% versus 31 October 2019 (+ 9% excluding events)

 

· Adjusted EBITDA is 12% up for the period, with a margin improvement of 3 percentage points to 32% versus the previous period.

 

· Strong cash flow from operations, which has grown 8% versus the previous period.

 

· Net debt has risen from £41.2m at June 2020 to £51.4m, with strong operating cash flow offset by dividend payment and purchase of IT equipment.

 

The Group has continued to perform well despite the challenging macro environment, with subscription revenue growth of 7% in line with our recent half-year results. We have started to see momentum in sales order growth at the end of Q3 and the start of Q4 2020, which is encouraging, and will be a key driver of revenues in 2021. Despite the headwind impact of COVID-19 on our events revenue, full year total Group revenues are expected to be flat.

 

In line with our normal renewal cycle we still have work to do in November and December to secure renewal business, but the momentum we are currently seeing gives us confidence that we will deliver a strong finish to the year and start the new financial year with a significant percentage of our annual revenues already secure.

 

Full Year Adjusted EBITDA for the current financial year is expected to be in line with the Board's expectations.

 

The financial results for the year ending 31 December 2020 will be announced on 1 March 2021 and will be available on our website www.globaldata.com

 

 

ENQUIRIES:

GlobalData Plc

Mike Danson, Chief Executive Officer 0207 936 6400

Graham Lilley, Chief Financial Officer

Brokers

Bill Hutchings/ Mose Adigun - J.P. Morgan Cazenove (Nomad and joint broker) 0207 742 4000

Sam Barnett - HSBC (Joint broker) 0207 991 8888

Erik Anderson/ Alina Vaskina - Panmure Gordon (Joint Broker) 020 7886 2500

Hudson Sandler

Nick Lyon 0207 796 4133

 

Adjusted EBITDA - Earnings before interest, tax, depreciation, amortisation adjusted for costs associated with acquisitions, restructuring of the Group, share based payments, impairment, unrealised operating exchange rate movements and impact of foreign exchange contracts.

Forward contracted revenue - Deferred revenue plus contracted revenue for the next 2021 months with a future billing date.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGRGGUPUPPC
Date   Source Headline
2nd May 202410:16 amRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSAppointment of Joint Broker
23rd Apr 20242:44 pmRNSResults of Annual General Meeting
27th Mar 20247:00 amRNSAnnual Report for year ended 31 December 2023
12th Mar 20241:35 pmRNSDirector/PDMR Shareholding
12th Mar 20241:30 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSFull Year Results
1st Feb 20243:49 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSInvestor and Analyst Seminar
11th Jan 20247:00 amRNSTrading Update & Announcement of Investor Seminar
29th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSInvestment in Healthcare Division by Inflexion
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 202310:48 amRNSDirector/PDMR Shareholding
13th Sep 202310:41 amRNSDirector/PDMR Shareholding
8th Aug 20235:41 pmRNSDirector/PDMR Shareholding
8th Aug 20235:35 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSHalf Year Results
25th Jul 20232:58 pmRNSResults of General Meeting
7th Jul 20237:00 amRNSNotice of General Meeting
30th Jun 202310:00 amRNSDirector/PDMR Shareholding
25th Apr 20233:34 pmRNSResult of AGM
25th Apr 20237:00 amRNSAGM Trading Update and Notice of AI Seminar
29th Mar 20237:00 amRNSNotice of Annual General Meeting 2023
17th Mar 20236:02 pmRNSAnnual Report for year ended 31 December 2022
27th Feb 20237:00 amRNSFull Year Results
27th Jan 20234:31 pmRNSDirector/PDMR Shareholding
27th Jan 20234:26 pmRNSHolding(s) in Company
27th Jan 20239:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSCapital Markets Day
18th Jan 202311:47 amRNSPDMR Dealing
10th Jan 20237:00 amRNSFull year trading update
10th Nov 20224:41 pmRNSSecond Price Monitoring Extn
10th Nov 20224:36 pmRNSPrice Monitoring Extension
17th Oct 20229:44 amRNSHoling(s) in Company
17th Oct 20228:44 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Sep 202210:59 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompletion of TS Lombard Acquisition
15th Aug 20227:00 amRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS£82m Share Scheme Vests for 146 Employees
10th Aug 20227:00 amRNS£410million Debt Financing Facility
1st Aug 20227:00 amRNSHalf Year Results
20th Jul 20227:00 amRNSAppointment of Joint Broker
15th Jul 20227:00 amRNSNotice of Interim Results
28th Jun 202212:45 pmRNSAnnual Report FY2021
26th Apr 202212:32 pmRNSResults of AGM
4th Apr 20221:14 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.